Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

著者: Martin Faßnacht, Alfredo Berruti, Éric Baudin, Michael J. Demeure, Jill Gilbert, Harm R. Haak, Matthias Kroiß, David I. Quinn, Elizabeth Hesseltine, Cristina L. Ronchi, Massimo Terzolo, Toni K. Choueiri, Srinivasu Poondru, Tanya Fleege, Ramona Rorig, Jihong Chen, Andrew Stephens, Francis P. Worden, Gary D. Hammer - The Lancet 2015 被引用: 333